+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Fabry Disease Treatment Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025

  • ID: 4803331
  • Report
  • Region: Global
  • 100 pages
  • Infinium Global Research
UP TO OFF
until Dec 31st 2019
1 of 3

FEATURED COMPANIES

  • Amicus Therapeutics Inc.
  • Avrobio Inc.
  • Greenovation Biotech GmbH
  • ISU Abxis Co Ltd.
  • Moderna Therapeutics Inc.
  • Sanofi S.A.
  • MORE
The report on the global fabry disease treatment market provides qualitative and quantitative analysis for the period from 2017 to 2025. The report predicts the global fabry disease treatment market to grow with a healthy CAGR over the forecast period from 2019-2025. The study on fabry disease treatment market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2017 to 2025.

The report on fabry disease treatment market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global fabry disease treatment market over the period of 2017 to 2025. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global fabry disease treatment market over the period of 2017 to 2025. Further, Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings
1) Drivers
  • Growing incidences of genetic disorders and increasing awareness
2) Restraints
  • High cost associated with the enzyme replacement therapy
3) Opportunities
  • Increasing number of clinical trials
Research Methodology

A) Primary Research
The primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include
1. Key Opinion Leaders associated with the author
2. Internal and External subject matter experts
3. Professionals and participants from the industry

The primary research respondents typically include
1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/ country managers
5. Vice President level executives.

B) Secondary Research
Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. Each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.

The secondary sources of the data typically include
1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies

Segment Covered
The global fabry disease treatment market is segmented on the basis of treatment type.

The Global Fabry Disease Treatment Market by Treatment Type
  • Enzyme Replacement Therapy
  • Chaperone Treatment
  • Substrate Reduction Therapy
  • Organ-specific Treatment
Company Profiles
The companies covered in the report include
  • Sanofi S.A.
  • Shire Plc.
  • Amicus Therapeutics Inc.
  • JCR Pharmaceuticals Co Ltd.
  • Avrobio Inc.
  • ISU Abxis Co Ltd.
  • Idorsia Pharmaceuticals Ltd.
  • Protalix Biotherapeutics Inc.
  • Moderna Therapeutics Inc.
  • Greenovation Biotech GmbH
What does this report deliver?
1. Comprehensive analysis of the global as well as regional markets of the fabry disease treatment market.
2. Complete coverage of all the segments in the fabry disease treatment market to analyze the trends, developments in the global market and forecast of market size up to 2025.
3. Comprehensive analysis of the companies operating in the global fabry disease treatment market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Amicus Therapeutics Inc.
  • Avrobio Inc.
  • Greenovation Biotech GmbH
  • ISU Abxis Co Ltd.
  • Moderna Therapeutics Inc.
  • Sanofi S.A.
  • MORE
1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches

2. Executive Summary
2.1. Fabry Disease Treatment Market Highlights
2.2. Fabry Disease Treatment Market Projection
2.3. Fabry Disease Treatment Market Regional Highlights

3. Global Fabry Disease Treatment Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Porter's Five Forces Analysis
3.4. Growth Matrix Analysis
3.4.1. Growth Matrix Analysis by Treatment Type
3.4.2. Growth Matrix Analysis by Region
3.5. Value Chain Analysis of Fabry Disease Treatment Market

4. Fabry Disease Treatment Market Macro Indicator Analysis

5. Global Fabry Disease Treatment Market by Treatment Type
5.1. Enzyme Replacement Therapy
5.2. Chaperone Treatment
5.3. Substrate Reduction Therapy
5.4. Organ-specific Treatment

6. Global Fabry Disease Treatment Market by Region 2019-2025
6.1. North America
6.1.1. North America Fabry Disease Treatment Market by Treatment Type
6.1.2. North America Fabry Disease Treatment Market by Country
6.2. Europe
6.2.1. Europe Fabry Disease Treatment Market by Treatment Type
6.2.2. Europe Fabry Disease Treatment Market by Country
6.3. Asia-Pacific
6.3.1. Asia-Pacific Fabry Disease Treatment Market by Treatment Type
6.3.2. Asia-Pacific Fabry Disease Treatment Market by Country
6.4. RoW
6.4.1. RoW Fabry Disease Treatment Market by Treatment Type
6.4.2. RoW Fabry Disease Treatment Market by Sub-region

7. Company Profiles and Competitive Landscape
7.1. Competitive Landscape in the Global Fabry Disease Treatment Market
7.2. Companies Profiles
7.2.1. Sanofi S.A.
7.2.2. Shire Plc.
7.2.3. Amicus Therapeutics Inc.
7.2.4. JCR Pharmaceuticals Co Ltd.
7.2.5. Avrobio Inc.
7.2.6. ISU Abxis Co Ltd.
7.2.7. Idorsia Pharmaceuticals Ltd.
7.2.8. Protalix Biotherapeutics Inc.
7.2.9. Moderna Therapeutics Inc.
7.2.10. Greenovation Biotech GmbH

8. Appendix
8.1. Primary Research Findings and Questionnaire

Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Sanofi S.A.
  • Shire Plc.
  • Amicus Therapeutics Inc.
  • JCR Pharmaceuticals Co Ltd.
  • Avrobio Inc.
  • ISU Abxis Co Ltd.
  • Idorsia Pharmaceuticals Ltd.
  • Protalix Biotherapeutics Inc.
  • Moderna Therapeutics Inc.
  • Greenovation Biotech GmbH
Note: Product cover images may vary from those shown
Adroll
adroll